Form 4: CareDx Director Michael Goldberg Granted Over 12,000 Restricted Stock Units

CareDx, Inc. Director Michael Goldberg was granted 12,103 shares of common stock in the form of restricted stock units on June 13, 2025, as reported in a recent SEC Form 4 filing.

Summary

• Michael Goldberg, a Director of CareDx, Inc. (CDNA), acquired 12,103 shares of common stock on June 13, 2025.
• These shares were granted as Restricted Stock Units (RSUs) at a price of $0 per share.
• Following this transaction, Mr. Goldberg beneficially owns 152,998 shares of CareDx common stock.
• The RSUs are set to vest in a single installment on the earlier of June 13, 2026, or the day immediately prior to the first annual meeting of stockholders held by CareDx, Inc. after June 13, 2025.

Sentiment

Score: 7

Explanation: The grant of RSUs to a director is a positive signal of alignment between management and shareholder interests, and a standard compensation practice. It's not a major event but generally viewed favorably as it incentivizes long-term performance.

Positives

• The grant of 12,103 Restricted Stock Units (RSUs) to Director Michael Goldberg aligns his interests with long-term shareholder value.
• RSU grants are a common form of executive and director compensation, indicating standard corporate governance practices.

Risks

• The value of the granted Restricted Stock Units (RSUs) is subject to the future performance of CareDx, Inc.'s stock price.
• Vesting of the RSUs is contingent upon continued service until the specified vesting date.

Future Outlook

The 12,103 Restricted Stock Units granted to Director Michael Goldberg are scheduled to vest in a single installment on the earlier of June 13, 2026, or the day immediately prior to the first annual meeting of stockholders held by CareDx, Inc. after June 13, 2025.

Industry Context

This Form 4 filing reflects a routine equity compensation grant to a director, a common practice across various industries to incentivize long-term commitment and align management interests with shareholder returns.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) to a director is a standard compensation mechanism widely adopted by publicly traded companies, particularly in the biotechnology and healthcare sectors, to retain talent and align executive incentives with company performance.
• While specific comparable companies or projects are not detailed in this filing, RSU grants are a benchmark practice for director compensation across the S&P 500 and NASDAQ-listed firms.

Related Party Transactions

• The acquisition of 12,103 Restricted Stock Units by Michael Goldberg, a Director of CareDx, Inc., constitutes a related party transaction as it involves an insider receiving equity compensation from the company.

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's interests with shareholders, potentially encouraging decisions that enhance long-term stock value.
• Management/Directors: Michael Goldberg's compensation package is enhanced, incentivizing his continued service and performance.

Next Steps

• The 12,103 Restricted Stock Units (RSUs) will vest on the earlier of June 13, 2026, or the day immediately prior to the first annual meeting of stockholders held by CareDx, Inc. after June 13, 2025.

Key Dates

Recommendation

Keywords

CareDx, CDNA, Michael Goldberg, SEC Form 4, Restricted Stock Units, RSU, Insider Transaction, Director Compensation, Equity Grant, Beneficial Ownership